Developments Inversago Pharma accepts $1.1-billion offer from Novo Nordisk Closely-held Inversago Pharma of Montreal agreed to be acquired by Denmark’s Novo Nordisk for up to $1.1-billion (U.S.) in cash if certain development and commercial milestones are achieved. Inversago Pharma is a... August 10, 2023